“In Silico Design, ADMET Prediction and Molecular Docking Studies of Novel Cyanopyridine-Substituted 1,3,5-Triazine Derivatives as Potential Anti-Alzheimer Agents”, Int J Med Sci H Care Res Inn, vol. 1, no. 2, pp. 16–39, Jul. 2026, doi: 10.5281/zenodo.21498307.